Table 1.

Demographic, baseline features of 127 children or adolescence with COVID-19. Values are numbers, mean±SD (standard deviation) or medians (interquartile ranges) unless stated otherwise.

	Total	Mild	Moderate	Severe and Critical
No. of patients	127	57	63	7
Age, yr	7.27 (4.85)	8.49 (4.46)	5.73 (4.85)	1.64 (2.85)
Distribution, No. of patients
0–12m	28	11	12	5
13–24m	2	0	1	1
>25 m, ≤5y	14	8	6	0
>5y, ≤10y	45	19	25	1
>10y	38	19	19	0
Male (%)	67.72	71.93	66.67	71.43
Weight, kg	35.06 (23.9)	36.76 (24.93)	36.28 (22.85)	11.60 (8.08)
Height, cm	124.5 (36.49)	128.25 (35.10)	126.90 (34.78)	78.80 (27.58)
Vital Signs, median [IQR]
Temperature, °C	36.5 [36.2–36.8]	36.5 [36.2–36.7]	36.5 [36.3–36.9]	36.7 [36.2–37.0]
Pulse, per/min	96 [88–110]	96 [90–107]	93 [88–101]	145 [110–160]
Respiratory rate, per/min	22 [20–26]	23 [20–25]	22 [20–25]	26 [25–45]
Comorbidity
Acute lymphoblastic leukaemia	2	0	1	1
Intussusception	1	0	0	1
Atrial septal defect	3	1	0	2
Intracranial malignant tumour	1	0	0	1
Intracranial haemorrhage	1	0	1	0
Co-infection
Mycoplasma IgM (+)	60	36	21	3
CMV IgM (+)	4	0	4	0
CMV IgG (+)	38	15	21	2
EB IgM/VCA (+)	3	1	2	0
EB IgG/VCA (+)	49	21	24	4
Lenghth days of hospitalisation (d)	15.41 (7.86)	14.02 (5.81)	15.24 (6.78)	30.00 (19.58)
Fatal or MV	2	0	0	2

COVID-19, coronavirus disease 2019; CMV, cytomegalovirus; EBV, Epstein-Barr virus. MV, mechanical ventilation.